MULTIMODALITY IMAGING OF COVID-19 PNEUMONIA : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/19gyvg96Keywords:
Imaging, covid-19, pneumoniaAbstract
Background: Reversible transcription polymerase chain reaction (RT-PCR) nasopharyngeal or oropharyngeal swab tests that yield a positive result can establish the diagnosis of COVID-19. Due to the high prevalence of false-negative findings, especially in the early stages of the disease, and the patchy availability of testing, a methodical approach to diagnosis that incorporates radiologic imaging is required.
Aims : This systematic review is to review the multimodality imaging of patients with COVID-19 pneumonia.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed and SAGEPUB, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 22.043 articles, whereas the results of our search on SAGEPUB brought up 19.007 articles. The results of the search conducted for the last year of 2014 yielded a total 173 articles for PubMed and 98 articles for SAGEPUB. In the end, we compiled a total of 6 papers, 5 of which came from PubMed and 1 of which came from SAGEPUB. We included five research that met the criteria.
Conclusion: In summary, owing to the SARS-CoV-2 pandemic, it is critical to understand the typical and atypical imaging features of COVID-19 pneumonia as well as how they change over time on CXR and HRCT. When evaluating hospitalized and critically sick patients in a serial fashion, as well as in places with high levels of contagion, computed tomography (CXR) may be the initial imaging modality employed
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Original Research Thoracic Imaging. 2020;
Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Original Research Statements and Guidelines. 2020;
Buonsenso D, Piano A, Raffaelli F, Bonadia N, de Gaetano DK. Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak [Internet]. 2020. Available from: https://gisanddata.
Polverari G, Arena V, Ceci F. 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging. Journal of Thoracic Oncology. 2020;15(6):1078–80.
Altimier L. The 2020 COVID-19 pandemic. J Neonatal. 2020;26(4):183–91.
Wang D, Shang Y, Chen Y, Xia J, Tian W, Zhang T, et al. Clinical Value of COVID-19 Chest Radiography and High-Resolution CT Examination. Curr Med Imaging. 2022;18(7):780–6.
Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N. Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings? Diabetes Res Clin Pract. 2020 Aug 1;166.
Dietz M, Chironi G, Claessens YE, Farhad RL, Rouquette I, Serrano B, et al. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome. Eur J Nucl Med Mol Imaging. 2021 Jan 1;48(1):260–8.
Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, et al. Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect. Jpn J Radiol. 2022 Aug 1;40(8):800–13.
Bercean BA, Birhala A, Ardelean PG, Barbulescu I, Benta MM, Rasadean CD, et al. Evidence of a cognitive bias in the quantification of COVID-19 with CT: an artificial intelligence randomised clinical trial. Sci Rep. 2023 Dec 1;13(1).
Landini N, Colzani G, Ciet P, Tessarin G, Dorigo A, Bertana L, et al. Chest radiography findings of COVID-19 pneumonia: a specific pattern for a confident differential diagnosis. Sage Journals. 2021;63(12).
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020 Aug 1;277(8):2251–61.
Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020 Apr 30;382(18):1708–20.
Bikdeli B, Madhavan M V., Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. Vol. 75, Journal of the American College of Cardiology. Elsevier USA; 2020. p. 2950–73.
Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT Imaging and Differential Diagnosis of COVID-19. Canadian Association of Radiologists Journal. 2020 May 1;71(2):195–200.
Akl EA, Blazic I, Yaacoub S, Frija G, Chou R, Appiah JA, et al. Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. Vol. 298, Radiology. Radiological Society of North America Inc.; 2021. p. E63–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
